Evaluation of the Clinical Efficacy of Intensity-Modulated Radiotherapy Combined with Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma with Extrahepatic Oligometastasis and Prognostic Factors for Patient Survival

References

• Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA. 2021;71:209–249. doi:10.3322/caac.21660
   Google Scholar
• Rajyaguru DJ, Borgert AJ, Smith AL, et al. Radiofrequency ablation versus stereotactic body radiotherapy for localized hepatocellular carcinoma in nonsurgically managed patients: analysis of the national cancer database. J Clin Oncol. 2018;36(6):600–608. doi:10.1200/JCO.2017.75.3228
   PubMed Web of Science ®Google Scholar
• Kim N, Cheng J, Jung I, et al. Stereotactic body radiation therapy vs. radiofrequency ablation in Asian patients with hepatocellular carcinoma. J Hepatol. 2020;73(1):121–129. doi:10.1016/j.jhep.2020.03.005
   PubMed Web of Science ®Google Scholar
• He J, Zeng Z-C, Tang Z-Y, et al. Clinical features and prognostic factors in patients with bone metastases from hepatocellular carcinoma receiving external beam radiotherapy. Cancer. 2009;115(12):2710–2720. doi:10.1002/cncr.24300
   PubMed Web of Science ®Google Scholar
• Zhou L-Y, Zeng Z-C, Fan J, et al. Radiotherapy treatment of adrenal gland metastases from hepatocellular carcinoma: clinical features and prognostic factors. BMC Cancer. 2014;14:878. doi:10.1186/1471-2407-14-878
   PubMed Web of Science ®Google Scholar
• Raoul J-L, Forner A, Bolondi L, Cheung TT, Kloeckner R, De Baere T. Updated use of TACE for hepatocellular carcinoma treatment: how and when to use it based on clinical evidence. Cancer Treat Rev. 2019;72:28–36. doi:10.1016/j.ctrv.2018.11.002
   PubMed Web of Science ®Google Scholar
• Zeng Z-C, Tang Z-Y, Fan J, et al. A comparison of chemoembolization combination with and without radiotherapy for unresectable hepatocellular carcinoma. Cancer J. 2004;10(5):307–316. doi:10.1097/00130404-200409000-00008
   PubMed Web of Science ®Google Scholar
• Huo YR, Eslick GD. Transcatheter arterial chemoembolization plus radiotherapy compared with chemoembolization alone for hepatocellular carcinoma: a systematic review and meta-analysis. JAMA Oncol. 2015;1(6):756–765. doi:10.1001/jamaoncol.2015.2189
   PubMed Web of Science ®Google Scholar
• Binghui Y, Wenming C, Xiaojun Z, et al. 原发性肝癌规范化诊治的专家共识 [Expert consensus on standardized diagnosis and treatment of primary liver cancer]. 内科理论与实践. 2009;4(04):353–360.
   Google Scholar
• Uka K, Aikata H, Takaki S, et al. Clinical features and prognosis of patients with extrahepatic metastases from hepatocellular carcinoma. World J Gastroenterol. 2007;13(3):414–420. doi:10.3748/wjg.v13.i3.414
   PubMed Web of Science ®Google Scholar
• Llovet JM, Burroughs A, Bruix J. Hepatocellular carcinoma. Lancet. 2003;362(9399):1907–1917. doi:10.1016/S0140-6736(03)14964-1
   PubMed Web of Science ®Google Scholar
• Zhan H, Zhao X, Lu Z, Yao Y, Zhang X. Correlation and survival analysis of distant metastasis site and prognosis in patients with hepatocellular carcinoma. Front Oncol. 2021;11:652768. doi:10.3389/fonc.2021.652768
   PubMed Web of Science ®Google Scholar
• Kai M, Jie W. 肝癌合并肝外转移的外科治疗现状 [Present treatment situation of hepatocellular carcinoma with extrahepatic metastasis]. 中华外科杂志 [Zhonghua Wai Ke Za Zhi]. 2019;57(06):466–470.
   PubMedGoogle Scholar
• Yoon JH, Goo YJ, Lim C-J, et al. Features of extrahepatic metastasis after radiofrequency ablation for hepatocellular carcinoma. World J Gastroenterol. 2020;26(32):4833–4845. doi:10.3748/wjg.v26.i32.4833
   PubMed Web of Science ®Google Scholar
• Jung I-H, Yoon SM, Kwak J, et al. High-dose radiotherapy is associated with better local control of bone metastasis from hepatocellular carcinoma. Oncotarget. 2017;8(9):15182–15192. doi:10.18632/oncotarget.14858
   PubMedGoogle Scholar
• Gutiontov SI, Pitroda SP, Weichselbaum RR. Oligometastasis: past, Present, future. Int J Radiat Oncol Biol Phys. 2020;108(3):530–538. doi:10.1016/j.ijrobp.2020.02.019
   PubMed Web of Science ®Google Scholar
• Jang JW, Kay CS, You CR, et al. Simultaneous multitarget irradiation using helical tomotherapy for advanced hepatocellular carcinoma with multiple extrahepatic metastases. Int J Radiat Oncol Biol Phys. 2009;74(2):412–418. doi:10.1016/j.ijrobp.2008.08.034
   PubMed Web of Science ®Google Scholar
• Uchino K, Tateishi R, Shiina S, et al. Hepatocellular carcinoma with extrahepatic metastasis: clinical features and prognostic factors. Cancer. 2011;117(19):4475–4483. doi:10.1002/cncr.25960
   PubMed Web of Science ®Google Scholar
• Zhang X-P, Gao Y-Z, Chen Z-H, et al. An eastern hepatobiliary surgery hospital/portal vein tumor thrombus scoring system as an aid to decision making on hepatectomy for hepatocellular carcinoma patients with portal vein tumor thrombus: a multicenter study. Hepatology. 2019;69(5):2076–2090. doi:10.1002/hep.30490
   PubMed Web of Science ®Google Scholar
• Zhou J, Sun H, Wang Z, et al. Guidelines for the diagnosis and treatment of hepatocellular carcinoma (2019 edition). Liver Cancer. 2020;9(6):682–720. doi:10.1159/000509424
   PubMed Web of Science ®Google Scholar
• Lu J, Zhang X-P, Zhong B-Y, et al. Management of patients with hepatocellular carcinoma and portal vein tumour thrombosis: comparing east and west. Lancet Gastroenterol Hepatol. 2019;4(9):721–730. doi:10.1016/S2468-1253(19)30178-5
   PubMed Web of Science ®Google Scholar
• Wei X, Jiang Y, Zhang X, et al. Neoadjuvant three-dimensional conformal radiotherapy for resectable hepatocellular carcinoma with portal vein tumor thrombus: a randomized, open-label, multicenter controlled study. J Clin Oncol. 2019;37(24):2141–2151. doi:10.1200/JCO.18.02184
   PubMed Web of Science ®Google Scholar
• Hallemeier CL, Apisarnthanarax S, Dawson LA. BCLC 2022 update: important advances, but missing external beam radiotherapy. J Hepatol. 2022;76(5):1237–1239. doi:10.1016/j.jhep.2021.12.029
   PubMed Web of Science ®Google Scholar
• Jihye C, Jinsil S. Application of radiotherapeutic strategies in the BCLC-defined stages of hepatocellular carcinoma. Liver Cancer. 2012;1(3–4):216–225. doi:10.1159/000343836
   PubMed Web of Science ®Google Scholar
• Rim CH, Cheng J, Huang W-Y, et al. An evaluation of hepatocellular carcinoma practice guidelines from a radiation oncology perspective. Radiother Oncol. 2020;148:73–81. doi:10.1016/j.radonc.2020.03.027
   PubMed Web of Science ®Google Scholar
• Choi Y, Kim J, Lee I, Seong J. Dose escalation using helical tomotherapy improves local control in spine metastases from primary hepatic malignancies. Liver Int. 2014;34(3):462–468. doi:10.1111/liv.12260
   PubMed Web of Science ®Google Scholar
• Kim N, Cheng J, Huang W-Y, et al. Dose-response relationship in stereotactic body radiation therapy for hepatocellular carcinoma: a pooled analysis of an Asian liver radiation therapy group study. Int J Radiat Oncol Biol Phys. 2021;109(2):464–473. doi:10.1016/j.ijrobp.2020.09.038
   PubMed Web of Science ®Google Scholar
• Byun HK, Kim HJ, Im YR, Kim DY, Han K-H, Seong J. Dose escalation by intensity modulated radiotherapy in liver-directed concurrent chemoradiotherapy for locally advanced BCLC stage C hepatocellular carcinoma. Radiother Oncol. 2019;133:1–8. doi:10.1016/j.radonc.2018.12.025
   PubMed Web of Science ®Google Scholar
• Kuo T-M, Chang K-M, Cheng T-I, Kao K-J. Clinical factors predicting better survival outcome for pulmonary metastasectomy of hepatocellular carcinoma. Liver Cancer. 2017;6(4):297–306. doi:10.1159/000477134
   PubMed Web of Science ®Google Scholar
• European Association for the Study of the Liver, European Association for the Study of the Liver. EASL clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol. 2018;69(1):182–236. doi:10.1016/j.jhep.2018.03.019
   PubMed Web of Science ®Google Scholar
• Vogel A, Cervantes A, Chau I, et al.; ESMO Guidelines Committee. Hepatocellular carcinoma: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2018;29(Suppl4):iv238–iv255. doi:10.1093/annonc/mdy308
   PubMedGoogle Scholar
• Galun D, Mijac D, Filipovic A, Bogdanovic A, Zivanovic M, Masulovic D. Precision medicine for hepatocellular carcinoma: clinical perspective. J Pers Med. 2022;12(2):149. doi:10.3390/jpm12020149
   PubMed Web of Science ®Google Scholar